Ambulatory infusion centers provide a wide range of infusion therapies and nursing services to patients in an outpatient setting. This includes disease management, hydration therapy, antibiotic therapy, pain management, chemotherapy and many more. Such centers help manage complex chronic conditions in a cost effective manner without requiring hospital admission. The global Ambulatory Infusion Center Market is estimated to be valued at US$67.84 Billion in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for outpatient infusion centers is one of the major trends propelling the growth of the ambulatory infusion center market. Over the past few years, there has been a substantial increase in the number of outpatient visits for chronic disease management and other infusion therapies. This is mainly due to the disadvantages associated with traditional inpatient infusion treatments such as longer length of stay, higher costs involved, risks of hospital acquired infections etc. Ambulatory infusion centers offer several benefits like flexible timing, comfortable environment, specialized nursing care and lower costs. These centers have emerged as a cost-effective and efficient alternative to inpatient care for managing chronic conditions.
Strength: Ambulatory infusion centers offer convenience for patients by allowing them to receive infusions outside of hospitals. They provide flexibility in scheduling and shorter wait times compared to hospitals.
Weakness: Smaller ambulatory infusion centers may lack resources and staffing compared to hospitals. Staff training can also be more limited for specialized treatments.
Opportunity: The aging population and rise of chronic diseases is driving greater demand for infusion therapies. This growing patient pool represents an opportunity to expand services at ambulatory centers.
Threats: Economic downturns could threaten revenue streams if patients delay or cancel treatments due to costs. Strict regulations around drug storage and handling must also be followed to maintain quality standards.
The global ambulatory infusion center market is expected to witness high growth over the forecast period of 2024 to 2031. The market size for 2024 is estimated at US$67.84 billion and is anticipated to reach US$175.14 billion by 2031, registering a CAGR of 9.6%.
Regional analysis shows North America currently dominates the market, supported by reimbursement coverage and initiatives to shift care from hospitals. However, Asia Pacific is poised to grow the fastest due to a large patient population and government efforts to strengthen healthcare infrastructure in countries like China, India, and Japan.
Key players operating in the ambulatory infusion center market are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, PharMerica, and BD. These companies provide infusion drugs and services across a broad network of ambulatory centers. They are focused on further developing specialized therapies and enhancing accessibility through digital platforms.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it